Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Medtronic plc filings on SEC EDGAR ↗
Medtronic plc has completed the separation of its diabetes business, MiniMed Group, Inc., into an independent publicly traded company via a tax-free exchange offer. Medtronic exchanged its remaining 252,813,348 shares of MiniMed common stock for outstanding Medtronic ordinary shares in an offer that was 5.4x oversubscribed.
Medtronic EVP, Pres MedSurg and Americas Michael Marinaro Sells $1M of Stock
Michael Marinaro, EVP, Pres MedSurg and Americas, sold 10,420 shares of Medtronic plc at $96.00 a share, worth $1M in total on Oct 15, 2026. Shares held after the trade: 105,916 (-9.0%).
Medtronic Chairman and CEO Geoffrey Martha Sells $4.75M of Stock
Geoffrey Martha, Chairman and CEO, sold 50,000 shares of Medtronic plc at $95.00 a share, worth $4.75M in total on Oct 15, 2026. Shares held after the trade: 277,866 (-15.3%).
Medtronic plc has commenced an exchange offer to distribute up to 225,361,295 shares of MiniMed Group, Inc. common stock to its shareholders in exchange for outstanding Medtronic ordinary shares. This transaction is part of a spin-off or demerger process where Medtronic is divesting its interest in MiniMed. The filing also notes a typographical correction regarding guaranteed delivery procedures in the previously filed prospectus.